WJWM
REGN icon

Williams Jones Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Williams Jones Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$626K Sell
810
-9
-1% -$6.89K 0.01% 320
2025
Q4 		$632K Buy
819
+2
+0.2% +$1.36K 0.01% 315
2025
Q3 		$459K Sell
817
-161
-16% -$91K 0.01% 358
2025
Q2 		$513K Sell
978
-95
-9% -$53K 0.01% 345
2025
Q1 		$681K Sell
1,073
-25
-2% -$17.2K 0.01% 291
2024
Q4 		$782K Sell
1,098
-715
-39% -$600K 0.01% 274
2024
Q3 		$1.91M Sell
1,813
-2
-0.1% -$2.23K 0.02% 199
2024
Q2 		$1.91M Buy
1,815
+36
+2% +$34.9K 0.02% 195
2024
Q1 		$1.71M Buy
1,779
+58
+3% +$55.2K 0.02% 210
2023
Q4 		$1.51M Sell
1,721
-85
-5% -$70K 0.02% 220
2023
Q3 		$1.49M Buy
1,806
+70
+4% +$55K 0.02% 215
2023
Q2 		$1.25M Hold
1,736
– – 0.02% 231
2023
Q1 		$1.43M Hold
1,736
– – 0.02% 231
2022
Q4 		$1.25M Hold
1,736
– – 0.02% 241
2022
Q3 		$1.2M Hold
1,736
– – 0.02% 244
2022
Q2 		$1.03M Buy
1,736
+15
+0.9% +$9.75K 0.02% 270
2022
Q1 		$1.2M Sell
1,721
-1
-0.1% -$633 0.02% 248
2021
Q4 		$1.09M Buy
1,722
+42
+3% +$25.8K 0.01% 251
2021
Q3 		$1.02M Sell
1,680
-12
-0.7% -$7.45K 0.01% 246
2021
Q2 		$945K Sell
1,692
-192
-10% -$97.3K 0.01% 257
2021
Q1 		$891K Buy
1,884
+39
+2% +$19K 0.01% 255
2020
Q4 		$891K Buy
1,845
+380
+26% +$205K 0.01% 233
2020
Q3 		$820K Buy
1,465
+256
+21% +$155K 0.02% 218
2020
Q2 		$754K Buy
+1,209
New +$686K 0.02% 220

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Williams Jones Wealth Management's REGN Position: Q1 2026 in Review

Williams Jones Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.1% in Q1 2026, selling an estimated $6.89K and leaving 810 shares worth $626K. The position accounts for 0.01% of the portfolio, ranked #320.

Williams Jones Wealth Management first reported a position in REGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.91M in Q2 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Williams Jones Wealth Management held 810 shares of Regeneron Pharmaceuticals worth $626K as of Q1 2026.
  • Williams Jones Wealth Management sold 9 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $6.89K.
  • Regeneron Pharmaceuticals made up 0.01% of Williams Jones Wealth Management's portfolio in Q1 2026, its #320 holding.
  • Williams Jones Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Williams Jones Wealth Management's Regeneron Pharmaceuticals position peaked at $1.91M in Q2 2024.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Williams Jones Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.